跳至主要内容
临床试验/DRKS00016164
DRKS00016164招募中2 期

Proton therapy of tumors of the head and neck area: Prospective recording of efficiency and side effects at standard clinical doses - Proto-R-H

niversitätsklinikum Dresden, Klinik für Strahlentherapie und Radioonkologie0 个研究点目标入组 456 人开始时间: 2018年12月20日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
456

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Head and neck tumors: squamous cell carcinomas, adenocarcinomas, rare histologies
  • - Age > 18 years
  • - ECOG < 2
  • - Indication for high-dose primary radiotherapy or radiochemotherapy or for high-dose adjuvant radiotherapy or radiochemotherapy
  • - Treatment (radiation dose, additional systemic therapies) according to current clinical standard possible and planned
  • - Ability to consent and the patient's present written consent

排除标准

  • - Lack of possibility of MRI planning (e.g. contraindications to performing an MRI)
  • - Lack of patient compliance
  • - Missing or limited possibility of reproducible positioning (e.g. due to severe limitation of patient mobility)
  • - metals in the region to be irradiated (e.g. internal fixator in the affected section of the cervical spine) if they interfere with dose distribution
  • - Tumors of the skull base or with irradiation area that reaches the skull base in large volume (--> include in Proto-R skull base)

研究者

发起方
niversitätsklinikum Dresden, Klinik für Strahlentherapie und Radioonkologie

相似试验